Start the conversation
The coronavirus pandemic is absolutely one of the biggest crises – and greatest tragedies – of this generation.
But trouble also spurs action – so new ways of thinking tackle new threats like COVID-19.
And more than any other, one word characterizes these new ideas.
I'm talking about "innovation."
Now, I don't think there's any doubt among scientists, doctors, and drug executives that COVID-19 has created a huge paradigm shift.
The pandemic is prompting company executives, researchers, government officials, and medical scientists to seek new ways to do things – as well as the technologies that can fuel those new approaches.
The bottom line: All these folks are looking to use existing technologies to tamp down on the coronavirus pandemic.
And once they've succeeded – as they will – these new ways of doing things will mostly be here to stay.
That means the technologies that made this all possible will be major beneficiaries going forward.
Three areas of technology stand to be the biggest winners of all.
Today, I'm going to show you those three winners. All told, the three segments I want to walk you through today are on their way to being worth more than $70 billion on a global basis.
And I'm also going to detail three investments that will allow you to ride these new tech waves – and profit – in an equally meaningful way.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.